The contribution of apixaban renal clearance to total clearance

Por Frost, Charles, Boyd, Rebecca A.
Publicado no J Thromb Thrombolysis (2015)

Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review

Por Byon, Wonkyung, Garonzik, Samira, Boyd, Rebecca A., Frost, Charles E.
Publicado no Clin Pharmacokinet (2019)

Effect of Activated Charcoal on Apixaban Pharmacokinetics in Healthy Subjects

Por Wang, Xiaoli, Mondal, Sabiha, Wang, Jessie, Tirucherai, Giridhar, Zhang, Donglu, Boyd, Rebecca A., Frost, Charles
Publicado em 2013

A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban

Por Frost, Charles, Song, Yan, Barrett, Yu Chen, Wang, Jessie, Pursley, Janice, Boyd, Rebecca A, LaCreta, Frank
Publicado no Clin Pharmacol (2014)

Effect of famotidine on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor

Por Upreti, Vijay V, Song, Yan, Wang, Jessie, Byon, Wonkyung, Boyd, Rebecca A, Pursley, Janice M, LaCreta, Frank, Frost, Charles E
Publicado em 2013

Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects

Por Upreti, Vijay V, Wang, Jessie, Barrett, Yu Chen, Byon, Wonkyung, Boyd, Rebecca A, Pursley, Janice, LaCreta, Frank P, Frost, Charles E
Publicado em 2013

The pharmacokinetics of PF-734200, a DPP-IV inhibitor, in subjects with renal insufficiency

Por Dai, Haiqing, Johnson, Susan L, Terra, Steven G, Marbury, Thomas C, Smith, William B, Alcorn, Harry, Boyd, Rebecca A, Wang, Rong, Nguyen, Tu T
Publicado em 2011

Evaluation of the effect of naproxen on the pharmacokinetics and pharmacodynamics of apixaban

Por Frost, Charles, Shenker, Andrew, Gandhi, Mohit D, Pursley, Janice, Barrett, Yu Chen, Wang, Jessie, Zhang, Donglu, Byon, Wonkyung, Boyd, Rebecca A, LaCreta, Frank
Publicado no Br J Clin Pharmacol (2014)

Overview of the Clinical Pharmacology of Ertugliflozin, a Novel Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor

Por Fediuk, Daryl J., Nucci, Gianluca, Dawra, Vikas Kumar, Cutler, David L., Amin, Neeta B., Terra, Steven G., Boyd, Rebecca A., Krishna, Rajesh, Sahasrabudhe, Vaishali
Publicado no Clin Pharmacokinet (2020)

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects

Por Frost, Charles, Nepal, Sunil, Wang, Jessie, Schuster, Alan, Byon, Wonkyung, Boyd, Rebecca A, Yu, Zhigang, Shenker, Andrew, Barrett, Yu Chen, Mosqueda-Garcia, Rogelio, LaCreta, Frank
Publicado em 2013

Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor

Por Frost, Charles E, Byon, Wonkyung, Song, Yan, Wang, Jessie, Schuster, Alan E, Boyd, Rebecca A, Zhang, Donglu, Yu, Zhigang, Dias, Clapton, Shenker, Andrew, LaCreta, Frank
Publicado no Br J Clin Pharmacol (2015)